Literature DB >> 22178500

The γ-secretase cleavage product of polycystin-1 regulates TCF and CHOP-mediated transcriptional activation through a p300-dependent mechanism.

David Merrick1, Hannah Chapin, Julie E Baggs, Zhiheng Yu, Stefan Somlo, Zhaoxia Sun, John B Hogenesch, Michael J Caplan.   

Abstract

Mutations in Pkd1, encoding polycystin-1 (PC1), cause autosomal-dominant polycystic kidney disease (ADPKD). We show that the carboxy-terminal tail (CTT) of PC1 is released by γ-secretase-mediated cleavage and regulates the Wnt and CHOP pathways by binding the transcription factors TCF and CHOP, disrupting their interaction with the common transcriptional coactivator p300. Loss of PC1 causes increased proliferation and apoptosis, while reintroducing PC1-CTT into cultured Pkd1 null cells reestablishes normal growth rate, suppresses apoptosis, and prevents cyst formation. Inhibition of γ-secretase activity impairs the ability of PC1 to suppress growth and apoptosis and leads to cyst formation in cultured renal epithelial cells. Expression of the PC1-CTT is sufficient to rescue the dorsal body curvature phenotype in zebrafish embryos resulting from either γ-secretase inhibition or suppression of Pkd1 expression. Thus, γ-secretase-dependent release of the PC1-CTT creates a protein fragment whose expression is sufficient to suppress ADPKD-related phenotypes in vitro and in vivo.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22178500      PMCID: PMC3264829          DOI: 10.1016/j.devcel.2011.10.028

Source DB:  PubMed          Journal:  Dev Cell        ISSN: 1534-5807            Impact factor:   12.270


  48 in total

1.  Polycystin-1, STAT6, and P100 function in a pathway that transduces ciliary mechanosensation and is activated in polycystic kidney disease.

Authors:  Seng Hui Low; Shivakumar Vasanth; Claire H Larson; Sambuddho Mukherjee; Nikunj Sharma; Michael T Kinter; Michelle E Kane; Tomoko Obara; Thomas Weimbs
Journal:  Dev Cell       Date:  2006-01       Impact factor: 12.270

2.  PKD1 interacts with PKD2 through a probable coiled-coil domain.

Authors:  F Qian; F J Germino; Y Cai; X Zhang; S Somlo; G G Germino
Journal:  Nat Genet       Date:  1997-06       Impact factor: 38.330

3.  Receptor-associated constitutive protein tyrosine phosphatase activity controls the kinase function of JAK1.

Authors:  S J Haque; Q Wu; W Kammer; K Friedrich; J M Smith; I M Kerr; G R Stark; B R Williams
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-05       Impact factor: 11.205

4.  The polycystic kidney disease 1 gene product mediates protein kinase C alpha-dependent and c-Jun N-terminal kinase-dependent activation of the transcription factor AP-1.

Authors:  T Arnould; E Kim; L Tsiokas; F Jochimsen; W Grüning; J D Chang; G Walz
Journal:  J Biol Chem       Date:  1998-03-13       Impact factor: 5.157

5.  Cystic renal neoplasia following conditional inactivation of apc in mouse renal tubular epithelium.

Authors:  Chao-Nan Qian; Jared Knol; Peter Igarashi; Fangming Lin; Uko Zylstra; Bin Tean Teh; Bart O Williams
Journal:  J Biol Chem       Date:  2004-11-18       Impact factor: 5.157

6.  Armadillo coactivates transcription driven by the product of the Drosophila segment polarity gene dTCF.

Authors:  M van de Wetering; R Cavallo; D Dooijes; M van Beest; J van Es; J Loureiro; A Ypma; D Hursh; T Jones; A Bejsovec; M Peifer; M Mortin; H Clevers
Journal:  Cell       Date:  1997-03-21       Impact factor: 41.582

7.  The polycystic kidney disease 1 gene product modulates Wnt signaling.

Authors:  E Kim; T Arnould; L K Sellin; T Benzing; M J Fan; W Grüning; S Y Sokol; I Drummond; G Walz
Journal:  J Biol Chem       Date:  1999-02-19       Impact factor: 5.157

8.  The polycystic kidney disease 1 (PKD1) gene encodes a novel protein with multiple cell recognition domains.

Authors:  J Hughes; C J Ward; B Peral; R Aspinwall; K Clark; J L San Millán; V Gamble; P C Harris
Journal:  Nat Genet       Date:  1995-06       Impact factor: 38.330

9.  Mechanical stimuli induce cleavage and nuclear translocation of the polycystin-1 C terminus.

Authors:  Veronique Chauvet; Xin Tian; Herve Husson; David H Grimm; Tong Wang; Thomas Hiesberger; Thomas Hieseberger; Peter Igarashi; Anton M Bennett; Oxana Ibraghimov-Beskrovnaya; Stefan Somlo; Michael J Caplan
Journal:  J Clin Invest       Date:  2004-11       Impact factor: 14.808

10.  Distinct molecular forms of beta-catenin are targeted to adhesive or transcriptional complexes.

Authors:  Cara J Gottardi; Barry M Gumbiner
Journal:  J Cell Biol       Date:  2004-10-18       Impact factor: 10.539

View more
  31 in total

1.  Polycystins and mechanotransduction: From physiology to disease.

Authors:  Christina Piperi; Efthimia K Basdra
Journal:  World J Exp Med       Date:  2015-11-20

Review 2.  Vasopressin and disruption of calcium signalling in polycystic kidney disease.

Authors:  Fouad T Chebib; Caroline R Sussman; Xiaofang Wang; Peter C Harris; Vicente E Torres
Journal:  Nat Rev Nephrol       Date:  2015-04-14       Impact factor: 28.314

3.  Polycystin-1 regulates bone development through an interaction with the transcriptional coactivator TAZ.

Authors:  David Merrick; Kavita Mistry; Jingshing Wu; Nikolay Gresko; Julie E Baggs; John B Hogenesch; Zhaoxia Sun; Michael J Caplan
Journal:  Hum Mol Genet       Date:  2019-01-01       Impact factor: 6.150

4.  Polycystin-1 negatively regulates Polycystin-2 expression via the aggresome/autophagosome pathway.

Authors:  Valeriu Cebotaru; Liudmila Cebotaru; Hyunho Kim; Marco Chiaravalli; Alessandra Boletta; Feng Qian; William B Guggino
Journal:  J Biol Chem       Date:  2014-01-23       Impact factor: 5.157

Review 5.  Polycystins and partners: proposed role in mechanosensitivity.

Authors:  Kevin Retailleau; Fabrice Duprat
Journal:  J Physiol       Date:  2014-03-31       Impact factor: 5.182

6.  Polycystin-1 interacts with TAZ to stimulate osteoblastogenesis and inhibit adipogenesis.

Authors:  Zhousheng Xiao; Jerome Baudry; Li Cao; Jinsong Huang; Hao Chen; Charles R Yates; Wei Li; Brittany Dong; Christopher M Waters; Jeremy C Smith; L Darryl Quarles
Journal:  J Clin Invest       Date:  2017-11-27       Impact factor: 14.808

7.  Identification of targets of IL-13 and STAT6 signaling in polycystic kidney disease.

Authors:  Erin E Olsan; Jonathan D West; Jacob A Torres; Nicholas Doerr; Thomas Weimbs
Journal:  Am J Physiol Renal Physiol       Date:  2018-03-07

8.  Canonical Wnt inhibitors ameliorate cystogenesis in a mouse ortholog of human ADPKD.

Authors:  Ao Li; Yuchen Xu; Song Fan; Jialin Meng; Xufeng Shen; Qian Xiao; Yuan Li; Li Zhang; Xiansheng Zhang; Guanqing Wu; Chaozhao Liang; Dianqing Wu
Journal:  JCI Insight       Date:  2018-03-08

9.  Human polycystin-2 transgene dose-dependently rescues ADPKD phenotypes in Pkd2 mutant mice.

Authors:  Ao Li; Xin Tian; Xiaoli Zhang; Shunwei Huang; Yujie Ma; Dianqing Wu; Gilbert Moeckel; Stefan Somlo; Guanqing Wu
Journal:  Am J Pathol       Date:  2015-10       Impact factor: 4.307

Review 10.  A cut above (and below): Protein cleavage in the regulation of polycystin trafficking and signaling.

Authors:  Valeria Padovano; Kavita Mistry; David Merrick; Nikolay Gresko; Michael J Caplan
Journal:  Cell Signal       Date:  2020-04-10       Impact factor: 4.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.